Eastern Bank’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.41M Hold
56,050
0.04% 146
2026
Q1
$2.25M Hold
56,050
0.04% 160
2025
Q4
$2.84M Hold
56,050
0.05% 128
2025
Q3
$1.63M Hold
56,050
0.03% 158
2025
Q2
$1.32M Hold
56,050
0.03% 170
2025
Q1
$1.35M Hold
56,050
0.03% 187
2024
Q4
$2.37M Hold
56,050
0.04% 156
2024
Q3
$2.48M Buy
+56,050
New +$2.13M 0.04% 160

Other funds holding VERA

Eastern Bank's VERA Position: Q2 2026 in Review

Eastern Bank held its Vera Therapeutics (VERA) position steady in Q2 2026 at 56,050 shares worth $2.41M. The position accounts for 0.04% of the portfolio, ranked #146.

Eastern Bank first reported a position in VERA in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.84M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Eastern Bank held 56,050 shares of Vera Therapeutics worth $2.41M as of Q2 2026.
  • Eastern Bank left its Vera Therapeutics share count unchanged in Q2 2026.
  • Vera Therapeutics made up 0.04% of Eastern Bank's portfolio in Q2 2026, its #146 holding.
  • Eastern Bank first reported a position in Vera Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Eastern Bank's Vera Therapeutics position peaked at $2.84M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.